# 2025-09858: Federal Agencies Want Better Prescription Drug Price Files, Please

2025-09858, Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule, is a Federal Register proposed rule from Treasury Department, Internal Revenue Service, Labor Department, Employee Benefits Security Administration, Health and Human Services Department published 2025-06-02, effective 2022-01-01; deemed significant under Executive Order 12866; PRIA reads it as touching household money (as of 2026-11-17).

- Canonical: https://policyrisk.com/federal-register/2025-09858
- As of: 2026-11-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-09858
- Title: Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule
- Type: Proposed Rule
- Agencies: Treasury Department; Internal Revenue Service; Labor Department; Employee Benefits Security Administration; Health and Human Services Department
- Citation: 90 FR 23303
- Published: 2025-06-02
- Effective: 2022-01-01
- Comments close: not stated
- Significant: yes (OIRA_API)
- Touches household money: yes
- Regulation identifier numbers: 0938-AV64, 1210-AC30, 1545-BR51
- Last updated: 2026-11-17

## In one line

Federal Agencies Want Better Prescription Drug Price Files, Please

## Summary

The government wants your thoughts on how to make prescription drug price files easier to use and more accurate under new transparency rules. This affects health plans and drug pricing info that helps people shop smarter. Comments are open until July 2, 2025, so speak up if you have ideas to improve the system!

## Abstract

This document is a request for information (RFI) regarding the prescription drug machine-readable file disclosure requirements in the Transparency in Coverage final rules. The Departments of Labor, Health and Human Services (HHS), and the Treasury (the Departments) are issuing this RFI to gather input regarding implementation of the prescription drug machine-readable file disclosure requirements under the Transparency in Coverage final rules, including what modifications to the disclosure requirements or additional technical implementation guidance might be necessary to better ensure the accurate and timely completion of the prescription drug file.

## Effects PRIA read

- Monthly public drug-price files required: benefit, low. If you are covered by a non-grandfathered group or individual health plan, the plan or issuer must publish a prescription drug machine-readable file each month that is free to access. The file must include, for each covered drug by National Drug Code (NDC), the negotiated rates and historical net p…
- Specific data elements required in files: benefit, low. The prescription drug file must include, per coverage option, the plan name and a HIOS identifier (14-digit, or 5-digit if 14-digit not available, or EIN if no HIOS), each drug's NDC and names, negotiated rates as dollar amounts, and historical net prices as dollar amounts. Negotiated and historica…
- Plan liability and monitoring for third parties: cost, medium. If an insured group health plan relies on its issuer via a written agreement, the issuer (not the plan) violates the rule if the issuer fails to provide the required prescription drug file. If a plan or issuer contracts with another party (for example, a third-party administrator or claims clearing…
- Enforcement stance and comment deadline: cost, medium. The Departments rescinded a prior general enforcement deferral and stated they will enforce the prescription drug file requirement "on a case-by-case basis"; Executive Order 14221 (issued February 25, 2025) directs the Departments to issue guidance or proposed regulatory action within 90 days to up…

## Related documents

- [2026-20447](https://policyrisk.com/federal-register/2026-20447): Transparency in Coverage, 2026-10-06
- [2026-17622](https://policyrisk.com/federal-register/2026-17622): Federal Independent Dispute Resolution Operations; Correction, 2026-08-28
- [2026-11140](https://policyrisk.com/federal-register/2026-11140): Federal Independent Dispute Resolution Operations, 2026-06-04
- [2026-09479](https://policyrisk.com/federal-register/2026-09479): Excepted Fertility Benefits, 2026-05-13
- [2026-03798](https://policyrisk.com/federal-register/2026-03798): Private Health Insurance; Transparency in Coverage; Extension of Comment Period, 2026-02-25
- [2025-23693](https://policyrisk.com/federal-register/2025-23693): Transparency in Coverage, 2025-12-23

## Sources
- [2025-09858 on federalregister.gov](https://www.federalregister.gov/documents/2025/06/02/2025-09858/request-for-information-regarding-the-prescription-drug-machine-readable-file-requirement-in-the)
- [2025-09858 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-06-02/pdf/2025-09858.pdf)

## Related
- [Previous: 2025-09819, Petition for Reconsideration of Action in Rulemaking Proceeding](https://policyrisk.com/federal-register/2025-09819)
- [Next: 2025-09892, Airworthiness Directives; Airbus Helicopters](https://policyrisk.com/federal-register/2025-09892)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-09858 (as of 2026-11-17).
